 This protocol is a phase IIa study that will prospectively investigate whether minocycline an antibiotic that showed neuroprotective effects in animal models can decrease the cognitive deficits associated with carotid endarterectomy. This trial will be a randomized, parallel-group design, double-blind, placebo controlled clinical trial conducted at the Brigham and Womens Hospital. 